• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VERYAN MEDICAL LTD BIOMIMICS 3D VASCULAR STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VERYAN MEDICAL LTD BIOMIMICS 3D VASCULAR STENT SYSTEM Back to Search Results
Catalog Number 142122-14
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Ischemia (1942); Pain (1994); Restenosis (4576)
Event Date 11/22/2023
Event Type  Injury  
Manufacturer Narrative
There was no reported device malfunction and the device was not returned for analysis.A review has been performed of the manufacturing certificate of conformance associated with this lot.There were no non-conformances or deviations which could be associated with this event.Based on the case information and related record review, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.The reported patient effects of restenosis leading to interventions, ischemia, claudication/leg pain, and worsening of peripheral arterial disease leading to additional surgical intervention, endovascular intervention or amputation are listed in the biomimics 3d instructions for use and are known patient effects of peripheral stenting procedures.There is no indication of a product quality issue with respect to the design, manufacture or labelling of the device.If further information regarding this event becomes available, a follow-up report will be submitted.
 
Event Description
The patient was treated as part of the mimics 3d usa post-market observational study.On (b)(6) 2021, the patient was implanted with one biomimics 3d (bm3d) stent in the left leg, a 6.0 x 125 mm stent which was used to treat a denovo lesion of the right superficial femoral artery (sfa) distal third to proximal popliteal.An antegrade approach was used and the lesion was prepared using atherectomy.On (b)(6) 2023, the site identified a restenosis of treated segment (target lesion).It was reported as possibly related to the device and not related to the procedure.It was target lesion-related.It required a percutaneous intervention on (b)(6) 2023 as the subject had rutherford class (rc) 4 symptoms.The intervention was performed on the sfa distal third to anterior tibial distal third.It involved percutaneous transluminal angioplasty (pta)/ standard balloon angioplasty, laser atherectomy and thrombectomy.It was reported as a target lesion/vessel revascularisation (tlr/tvr).The patient outcome was reported as resolved/recovered.The device remains implanted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOMIMICS 3D VASCULAR STENT SYSTEM
Type of Device
BIOMIMICS 3D VASCULAR STENT SYSTEM
Manufacturer (Section D)
VERYAN MEDICAL LTD
block 5
parkmore east business park
galway, H91 V 0TX
EI  H91 V0TX
Manufacturer Contact
alan mcdonagh
block 5
parkmore east business park
galway, H91 V-0TX
EI   H91 V0TX
MDR Report Key19069238
MDR Text Key339673176
Report Number3011632150-2024-00018
Device Sequence Number1
Product Code NIP
UDI-Device Identifier05391526850480
UDI-Public(01)05391526850480(17)230109(11)210610(10)0000092737
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P180003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 04/09/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/09/2023
Device Catalogue Number142122-14
Device Lot Number0000092737
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/13/2024
Initial Date FDA Received04/09/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured06/10/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ASPIRIN.; CLOPIDOGREL (PLAVIX).
Patient Outcome(s) Required Intervention;
Patient Age67 YR
Patient SexMale
Patient Weight71 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-